CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-22 | Reeve Emma Director | Sale 10b5-1 | −173 | $59.52 | $10K | 7,200 |
| 2023-05-22 | Reeve Emma Director | Option exercise 10b5-1 | +2,995 | $33.02 | $99K | 10,195 |
| 2023-05-22 | Reeve Emma Director | Sale 10b5-1 | −2,995 | $59.53 | $178K | 7,200 |
| 2023-05-22 | Reeve Emma Director | Option exercise 10b5-1 | +3,948 | $33.63 | $133K | 11,148 |
| 2023-05-22 | Reeve Emma Director | Sale 10b5-1 | −3,948 | $59.53 | $235K | 7,200 |
| 2023-05-22 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −173 | $33.63 | $6K | 994 |
| 2023-05-22 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,995 | $33.02 | $99K | 8,005 |
| 2023-05-22 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,948 | $33.63 | $133K | 10,052 |
| 2023-05-22 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,913 | $58.98 | $113K | 47,653 |
| 2023-05-22 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −100 | $59.66 | $6K | 47,553 |
| 2023-05-19 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −6,403 | $58.96 | $377K | 49,566 |
| 2023-05-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −788 | $58.71 | $46K | 55,969 |
| 2023-05-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −800 | $58.52 | $47K | 64,005 |
| 2023-05-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −7,248 | $58.50 | $424K | 56,757 |
| 2023-05-11 | Jacobson Allan Steven Director | Option exercise 10b5-1 | +23,000 | $10.85 | $250K | 35,348 |
| 2023-05-11 | Jacobson Allan Steven Director | Sale 10b5-1 | −19,040 | $54.78 | $1.0M | 16,308 |
| 2023-05-11 | Jacobson Allan Steven Director | Sale 10b5-1 | −2,860 | $56.35 | $161K | 13,448 |
| 2023-05-11 | Jacobson Allan Steven Director | Sale 10b5-1 | −1,100 | $56.99 | $63K | 12,348 |
| 2023-05-11 | Jacobson Allan Steven Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,000 | $10.85 | $250K | 0 |
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise 10b5-1 | +4,321 | $33.02 | $143K | 42,380 |
Page 38 of 41 · 804 trades